1. Most Discussed
  2. Gainers & Losers
CST $3.77

report from afeb meeting

  1. G'day,

    Cellestis have posted a brief report from the AFEB meeting on their website.

    AFEB Update

    The text of the report is:

    Update on QuantiFERON-TB
    Cellestis presents to the Armed Forces Epidemiology Board (18-02-03)
    On 18th February 2003, the Armed Forces Epidemiology Board ("AFEB") of the US military, a
    joint military and civilian expert advisory board, met and considered the use of QuantiFERON -
    TB in the US armed services. Dr. Jim Rothel from Cellestis and other speakers presented on
    the subject of TB testing as it applies to the US military. The logistical and medical advantages
    of QuantiFERON - TB were discussed, as were the benefits of applying the recent CDC
    guidelines for-TB use and subsequent TB treatment. The presentations broadly detailed how
    the use of-TB in accordance with the CDC guidelines should result in more accurate diagnosis
    of TB leading to lesser treatment for TB infection in the military.
    Cellestis believes the process was open and the issues clearly understood. Cellestis was
    pleased with all presentations, discussions and questions.
    AFEB will confirm its decision and report on its recommendations for the use of QuantiFERON
    TB in the US armed services in the next 6 to 9 weeks. At this time, Cellestis will report further



DISCLAIMER:
Before making any financial decisions based on what you read, always consult an advisor or expert.

The HotCopper website is operated by Report Card Pty Ltd. Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.

From time to time comments aimed at manipulating other investors may appear on these forums. Posters may post overly optimistic or pessimistic comments on particular stocks, in an attempt to influence other investors. It is not possible for management to moderate all posts so some misleading and inaccurate posts may still appear on these forums. If you do have serious concerns with a post or posts you should report a Terms of Use Violation (TOU) on the link above. Unless specifically stated persons posting on this site are NOT investment advisors and do NOT hold the necessary licence, or have any formal training, to give investment advice.

Top